Some problems and pitfalls in developing countries

Epilepsia

Volumn 44, Issue SUPPL. 1, 2003, Pages 38-42

  Murthy, J M K ^a  

^a CARE HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ALTERNATIVE MEDICINE; BEHAVIOR DISORDER; CLINICAL TRIAL; CONFERENCE PAPER; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; CURRICULUM; DEVELOPING COUNTRY; DRUG CHOICE; DRUG COST; DRUG EFFICACY; DRUG MARKETING; DRUG TOLERABILITY; ECONOMIC EVALUATION; EPILEPSY; GEOGRAPHY; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; MEDICAL EDUCATION; PATIENT COMPLIANCE; POLYPHARMACY; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REIMBURSEMENT; RELIGIOUS GROUP; SIDE EFFECT;

EID: 0037273165     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.44.s.1.3.x     Document Type: Conference Paper

References (45)

1. Scott RA, Lhatoo SD, Sander JWA. The treatment of epilepsy in developing countries: where do we go from here? Bull WHO 2001;79:344-51.
2. Shorvon SD, Framer PJ. Epilepsy in developing countries: a review of epidemiological socio-cultural and treatment aspects. Epilepsia 1988;29:36-54.
3. Eisler O, Lajtai L. Bridging the gaps: community based epilepsy caring program in Nepal. Epilepsia 1999;40(suppl 2):196-7.
4. Placencia M, Shorvon SD, Paredes V, et al. Epileptic seizures in an Andean region of Ecuador. Brain 1992;115:771-82.
5. Sridham R, Murthy BN. Prevalence and pattern of epilepsy in India. Epilepsia 1999;40:634-6.
6. Jallon P. Epilepsy in developing countries: ILAE workshop report. Epilepsia 1997;38:1143-51.
7. The World Bank. World development report. New York: Oxford Press, 1993:216-9.
8. Pedley T, Kale R. Epilepsy information for the developing world. Epilepsy Dig 1996;1:1.
9. The World Bank. Entering the 21st century: World development report, 1999/2000. New York: Oxford University Press, 2000.
10. United Nations. Handbook of international trade and development statistics, 1996-1997. New York: United Nations, 1999.
11. International Monetary Fund. Balance of payments statistics: yearbook, Part 2: world and regional tables 1998. Washington DC: International Monetary Fund, Publication Services, 1995.
12. De Bittencourt PRM, Admolekum B, Bharucha N, et al. Epilepsy in the tropics, II: clinical presentations, pathophysiology, immunologic diagnosis, economics, and therapy. Epilepsia 1996;37:1128-37.
13. Murray CJL, Lopez AD. The global and regional cause-of-death patterns in 1990. Bull WHO 1994;72:447-80.
14. Murray CJL, Lopez AD. Quantifying disability, data, methods and results. Bull WHO 1994;72:481-94.
15. Cokerell OC, Hart YM, Sander JWAS, et al. The cost of epilepsy in the United Kingdom: an estimation based on the result of two population based studies. Epilepsy Res 1994;18:249-60.
16. Begely GS, Annegers JF, Lairson DR, et al. Cost of epilepsy in the United States: a model based on incidence and prognosis. Epilepsia 1994;35:1230-43.
17. Caveness WF, Gallup GH Jr. A survey of public attitude toward epilepsy in 1979 with an indication of trends over the past thirty years. Epilepsia 1980;21:509-15.
18. Canger R, Cornaggia C. Public attitudes toward epilepsy in Italy: results of a survey and comparison with U.S.A and West German data. Epilepsia 1985;26:221-6.
19. Jensen R, Dam M. Public attitude toward epilepsy in Denmark. Epilepsia 1992;33:459-63.
20. Krauss GL, Gondek S, Krumholz A, et al. "The Scarlet E": the presentation of epilepsy in the English-language print media. Neurology 2000:54:1894-8.
21. Lai C-W, Huang X, Lai Y-HC, et al. Survey of public awareness, understanding, and attitude toward epilepsy in Henan Province, China. Epilepsia 1990;31:182-7.
22. Rwiza HT, Matuja WBP, Kilonzo GP, et al. Knowledge, attitude and practice toward epilepsy among rural Tanzania residents. Epilepsia 1993;34:1017-23.
23. Radhakrishnan K, Pandian JD, Santhoskumar R, et al. Prevalence, knowledge, attitude, and practice of epilepsy in Kerala, South India. Epilepsia 2000;41:1027-35.
24. Fandino-Franky J, Silfvenius H. World-wide disparities in epilepsy care: a Latin American outlook. Epilepsia 1999;40(suppl 8):48-54.
25. Gumnit RJ. Delivery of health care and socioeconomic issues. In: Engel J Jr, Pedley TA, eds. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven Publishers, 1997:2807-9.
26. Adamolekun B. Organization of health care: Nigeria. In: Engel J Jr, Pedley TA, eds. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven Publishers, 1997:2811-6.
27. Guerreiro CAM. Organization of health care: Brazil. In: Engel J Jr, Pedley TA, eds. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven Publishers, 1997:2817-23.
28. Mani KS. Epilepsy care in rural India. In: Murthy JMK, ed. Epilepsy: the Indian perspective. Hyderabad: CARE Foundation, 1999:173-84.
29. Stevens DL. How many neurologists? UK view. World Neurol 1996;11:1.
30. Mani KS. Global campaign against epilepsy: agenda for IEA/IES. Neurology India 1998;46:1-4.
31. Murthy JMK. Epilepsy care in urban India. In: Murthy JMK, ed. Epilepsy: the Indian perspective. Hyderabad: CARE Foundation, 1999:185-202.
32. Preux PM, Tiemagni F, Fodzo L, et al. Antiepileptic therapies in the Mifi Province in Cameroon. Epilepsia 2000;41:432-9.
33. Mani KS, Rangan G, Srinivas HV, et al. Epilepsy control with phenobarbital or phenytoin in rural south India: the Yelandur study. Lancet 2001;367:1316-20.
34. The III and IV Commission on Antiepileptic Drugs of the International League Against Epilepsy. Availability and distribution of antiepileptic drugs in developing countries. Epilepsia 1985;26:117-21.
35. Sawhney IMS, Lekhra OP, Shashi JS, et al. Evaluation of epilepsy management in a developing country: a prospective study of 407 patients. Acta Neurol Scand 1995;94:19-23.
36. Radhakrishnan K, Dinesh Nayak S, Pradeep Kumar S, et al. Profile of antiepileptic pharmacotherapy in a tertiary referral centre in south India: a pharmacoepidemiologic and pharmacoeconomic study. Epilepsia 1999;40:179-85.
37. Baldy-Moulinier M, Covanis A, D'Urso S, et al. Therapeutic strategies against epilepsy in Mediterranean countries: a report from an international collaborative survey. Seizure 1998;7:513-20.
38. Murthy JMK, Mohan Rao CH, et al. Clinical observations of juvenile myoclonic epilepsy in 131 patients: a study in south India. Seizure 1998;7:43-7.
39. World Health Organization. Division of Mental Health Initiative of support to people with epilepsy. Geneva: Doc. WHO/MNH/MND//93.3, WHO, 1980.
40. South African Medical Association and Neurological Association of South African Epilepsy Working Group. Epilepsy management in the primary health care level. South Afr Med J 2000;90:406-32.
41. Feksi AT, Kaamugisha J, Sander JWA, et al. Comprehensive primary health care aniepileptic drug treatment program in rural and semi-urban Kenya, ICBERG (International Community-based Epilepsy Research Group). Lancet 1991;337:406-9.
42. Placencia M, Sander JWA, Shorvon SD, et al. Antiepileptic drug treatment in a community health care setting in northern Ecuador: a prospective 12-month assessment. Epilepsy Res 1993:14:237-44.
43. Pal D, Das T, Chaudury G, et al. Randomised controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India. Lancet 1998;351:19-23.
44. Watts AE. A model for managing epilepsy in a rural community in Africa. Br Med J 1989;289:805-7.
45. Migard D, de Lactoix-Mignard CM. Neurocysticercosis and epilepsy: large improvement with a better environment. Epilepsia 1999;40(suppl 2):192.